Sociodemographic factors, biomarkers and comorbidities associated with post-acute COVID-19 sequelae in UK Biobank

Marta Alcalde-Herraiz1, Shahed Iqbal2, Jeffrey J Wallin2

  • 1Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.

Nature Communications
|July 30, 2025
PubMed

Insights

Long COVID and post-acute complications of SARS-CoV-2 infection (PACS) are linked to sociodemographic factors, biomarkers, and comorbidities. Identifying high-risk groups can inform public health strategies and targeted interventions.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Long-term sequelae of COVID-19, including Long COVID (LC) and post-acute complications of SARS-CoV-2 infection (PACS), present significant public health challenges.
  • Limited therapeutic options necessitate a deeper understanding of risk factors associated with these conditions.

Purpose of the Study:

  • To investigate the association between sociodemographic factors, clinical biomarkers, and comorbidities with the risk of developing Long COVID and PACS.
  • To differentiate risk factors contributing to LC versus PACS.

Main Methods:

  • Two case-control studies were conducted using data from the UK Biobank, including 8,668 participants for LC and 108,407 for PACS.
  • Analysis explored associations between various factors and the incidence of LC (self-reported symptoms) and PACS (clinically diagnosed complications).

Main Results:

  • Age and sex showed opposing associations with LC and PACS.
  • Obesity, socioeconomic deprivation, elevated C-reactive protein, triglycerides, HbA1c, cystatin C, urate, alanine aminotransferase, and comorbidities like CKD and COPD were associated with LC.
  • Decreased HDL cholesterol and IGF-1 were also linked to LC. Most identified factors for LC were also significant for PACS, with exceptions for alanine aminotransferase and vitamin D.

Conclusions:

  • Sociodemographic factors, biomarkers, and comorbidities play a role in the development of Long COVID and PACS.
  • Findings suggest potential mechanistic differences between LC and PACS.
  • Identifying high-risk individuals can guide targeted public health interventions, such as vaccination strategies.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
216
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
687
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
337
Biostatistics: Overview01:20

Biostatistics: Overview

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
372